IDEX Corporation stock holds above $240 as analysts maintain moderate buy view
Published on 08/18/2026 at 10:00 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
IDEX Corporation (ISIN US45167R1041) stock was quoted around $240 per share as of August 17, 2026, with shares up just over 34 percent since the start of the year according to recent market data. Per an analyst overview dated August 17, 2026, the company is expected to deliver full-year 2026 earnings per share between $8.70 and $8.85 and has an average 12-month price target of $260.80.
Analysts see earnings growth and valuation upside
Recent analyst coverage compiled on August 17, 2026 indicates that ten research firms currently follow IDEX Corporation, with eight rating the shares as a buy and two recommending holding the stock. This mix translates into a consensus rating that points to a generally positive stance on the company.
In that same analyst roundup, coverage highlights that IDEX reported earnings per share of $2.32 in its latest quarter, beating a consensus estimate of $2.11. The same report cites quarterly revenue of $920.6 million, which represents year-over-year growth of 6.4 percent. Those figures suggest that the company is not only outpacing expectations on profit but also expanding its top line compared with the same period a year earlier.
Looking ahead, the analyst summary notes that IDEX has guided for fiscal 2026 earnings per share in a range of $8.70 to $8.85. It also references guidance for third quarter 2026 EPS between $2.20 and $2.25. Taken together with the recent quarterly delivery of $2.32 in EPS, this guidance implies that management expects earnings to remain at a relatively high level through the rest of the year.
On valuation, the same analyst dataset shows an average 12-month price objective of $260.80 for IDEX shares. Compared with a recent closing level around $240, that target range suggests potential percentage upside in the low double digits if the company meets expectations and the market maintains its current earnings multiple.
Stock performance and technical backdrop
Market data pages that track IDEX Corporation stock show a last close in the vicinity of $240.39 to $240.50 on August 17, 2026 on the Cboe marketplace, with the quote expressed in USD. One such overview shows a last close price of $240.39, while another technical view cites $240.793 as the last trade, reinforcing that the stock is trading comfortably above the $240 mark.
The same consensus page notes that IDEX shares have gained 2.02 percent since January 1, 2026 and are up 0.66 percent over the past five trading sessions as of the close on August 17, 2026. For investors, the combination of modest recent gains and a strong year-to-date performance alongside positive earnings surprises can indicate that the stock is participating in a broader industrial recovery while still offering room for further appreciation.
A technical snapshot taken at 4:00 p.m. ET on August 17, 2026 shows IDEX closing at 240.793 USD, up 1.853 points or 0.78 percent for the session. That move confirms that buyers were willing to pay higher prices into the close, and it places the stock not far below the average analyst target of $254.50 to $260.80 highlighted in the consensus overview, underscoring that expectations for continued earnings growth are already partially reflected in the share price.
Another element of the trading profile is index and institutional participation. The analyst-focused report notes that institutional investors and hedge funds collectively own 97.96 percent of the company’s stock. High institutional ownership can amplify both positive and negative reactions to earnings and guidance, because large shareholders may adjust positions quickly when new information becomes available.
Board changes and governance signal
Alongside the earnings and valuation story, there has also been a recent governance development at IDEX Corporation. According to a current report on Form 8-K summarized by an SEC filing tracker, director L. Paris Watts-Stanfield resigned from the company’s board effective August 13, 2026. The same disclosure notes that following this resignation, the size of the board has been reduced to nine directors.
The 8-K description indicates that the resignation was effective immediately on August 13, 2026 and that the company did not attribute it to any disagreement with management or the board over operations or policies. For shareholders, a reduction in the total number of directors can modestly alter the balance of viewpoints at the board level but does not by itself change the company’s strategic direction. It does, however, highlight that IDEX continues to adjust its governance structure as the business evolves.
Investors often watch for such governance disclosures in tandem with earnings performance, because significant board changes sometimes foreshadow strategic shifts, portfolio pruning, or changes in capital allocation priorities. In the absence of any reported disputes, the latest director change at IDEX appears to be a contained event rather than a signal of immediate upheaval.
Consensus guidance and earnings quality
The analyst summary from August 17, 2026 emphasizes that IDEX’s most recent quarter showed both revenue expansion and an earnings beat. Reporting $2.32 in EPS against a consensus forecast of $2.11 translates into an earnings surprise of $0.21 per share. With quarterly revenue at $920.6 million, up 6.4 percent year over year, that combination indicates that the company is not merely cutting costs to achieve its targets but is generating higher sales as well.
From an earnings-quality perspective, revenue growth paired with profit outperformance tends to be viewed more favorably than a situation where EPS beats are driven mainly by expense reductions or share repurchases. If IDEX can sustain mid-single-digit or higher revenue growth while delivering EPS in the company’s stated target range of $8.70 to $8.85 for 2026, the positive analyst stance reflected in the moderate buy consensus could prove durable.
Furthermore, the provision of specific guidance for the third quarter of 2026, with a projected EPS band of $2.20 to $2.25, gives investors a concrete benchmark to track in the upcoming reporting cycle. Should the company again come in above the midpoint of that range, it would reinforce the narrative that the business is executing well against its plan. Conversely, if results fall below guidance, investors would reassess whether the current valuation multiple and price targets remain justified.
The consensus target price in the mid-$250s to slightly above $260 suggests that analysts see additional upside of at least $14 to $20 per share from a recent $240-level close. That implied return potential is not extreme, but when combined with the company’s history of earnings delivery and institutional sponsorship, it may be sufficient for investors who prioritize stability and incremental growth over highly speculative upside.
How IDEX makes its money
IDEX Corporation generates its revenue by supplying a broad range of highly engineered industrial products and solutions, with many of its businesses focused on fluid and metering technologies, health and science technologies, and fire and safety products. The company’s portfolio often centers on mission-critical components that customers integrate into larger systems and processes, making reliability and performance crucial selling points.
One representative product line that illustrates IDEX’s positioning is its portfolio of precision fluid pumps and metering systems used in industries such as chemical processing, water treatment, and food production. These products are designed to handle challenging operating environments, where accurate dosing and consistent flow rates are essential to maintaining quality and safety standards. By focusing on niches where customers are willing to pay for performance and durability, IDEX aims to sustain attractive margins and recurring aftermarket demand.
Beyond pumps and fluid-handling components, the company also participates in markets for specialty valves, engineered seals, and instrumentation. Many of these offerings address regulatory-driven needs, such as emissions control, contamination prevention, or strict sterility requirements in pharmaceutical or biotechnology applications. That type of exposure can provide a degree of resilience when industrial cycles soften, because regulatory compliance projects often proceed even when discretionary capital spending is curtailed.
In addition, IDEX’s fire and safety portfolio includes critical equipment used by emergency responders, from rescue tools to fire suppression systems. While the revenue contribution of this segment is smaller than that of the larger industrial platform, it supports the company’s identity as a supplier of products where failure is not an option. Such positioning can bolster pricing power and brand loyalty, which in turn support the earnings metrics highlighted in the latest analyst coverage.
IDEX Corporation stock at current levels
As of the close on August 17, 2026, IDEX Corporation stock traded at 240.793 USD on the Cboe venue, representing a gain of 0.78 percent for that session. With a year-to-date performance of 2.02 percent reflected in consensus market data and a five-day gain of 0.66 percent, the shares are showing steady progress rather than dramatic swings.
For investors assessing the name at current levels, the key numerical anchors are the latest reported quarterly EPS of $2.32 versus a $2.11 consensus, the 6.4 percent increase in quarterly revenue to $920.6 million, and management’s guidance for 2026 EPS between $8.70 and $8.85. Overlaying those figures with an average analyst price target of $260.80 suggests that the market is pricing IDEX as a solidly growing industrial company with credible prospects for further earnings expansion.
Read more
Market-based consensus overview for IDEX Corporation
Industrial solutions highlight: precision fluid pumps
Within its broad portfolio, one of IDEX Corporation’s most emblematic offerings is its range of precision fluid pumps and metering systems that serve chemical, water, and food processing plants around the world. These systems are engineered to deliver exact volumes of liquids, often under high pressure or in corrosive environments, where even small deviations can compromise product quality or process safety.
Customers typically deploy these pumps as part of continuous production lines, where uptime and repeatability are crucial. Over the life of the equipment, the total cost of ownership is heavily influenced by reliability and maintenance requirements, which encourages buyers to favor suppliers with proven track records. For IDEX, that dynamic supports a business model in which initial equipment sales are complemented by a recurring stream of parts, service, and upgrade opportunities.
The company’s specialization in such high-consequence applications also offers a degree of differentiation relative to more commoditized industrial components. Rather than competing solely on price, IDEX can emphasize performance metrics such as dosing accuracy, energy efficiency, and erosion resistance. In an environment where customers are under pressure to improve environmental footprints and reduce waste, those product attributes can strengthen the case for choosing IDEX solutions.
Shares supported by earnings delivery
IDEX Corporation stock closed at 240.793 USD on August 17, 2026 at 4:00 p.m. ET on the Cboe marketplace, marking a daily increase of 1.853 points or 0.78 percent. That closing price sits below but within sight of the average 12-month price target of $260.80 cited in current analyst consensus, indicating that the market has already recognized much of the company’s recent earnings progress while still leaving room for potential further gains if guidance is achieved.
Company facts
Company: IDEX Corporation Inc.
ISIN: US45167R1041
Ticker: IEX
Exchange: Cboe US / NYSE ecosystem
Price (as of August 17, 2026, 4:00 p.m. ET): $240.79 USD
Sector / Industry: Industrials / Machinery and industrial products
Index membership: S&P 500
